Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Chimeric |
Target | HER1 |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
KEGG |
Modotuximab (INN; formerly zatuximab [1] ) is a chimeric monoclonal antibody designed for the treatment of cancer. [2] It acts as an immunomodulator and binds to HER1. [3]